Navigation Links
Estrogen-Only Hormone Therapy May Reduce Breast Cancer Risk for Some

By Kathleen Doheny
HealthDay Reporter

THURSDAY, Dec. 9 (HealthDay News) -- In a finding that seems to counter the prevailing wisdom that any form of hormone replacement therapy raises the risk of breast cancer, a new look at some old data suggests that estrogen-only hormone therapy might protect a small subset of postmenopausal women against the disease.

"Exogenous estrogen [such as hormone therapy] is actually protective" in women who have a low risk for developing breast tumors, said study author Dr. Joseph Ragaz, a medical oncologist and clinical professor in the School of Population & Public Health at the University of British Columbia in Vancouver.

With his colleagues, Ragaz took another look at data from the Women's Health Initiative (WHI) study, a national trial that has focused on ways to prevent breast and colorectal cancer, as well as heart disease and fracture risk, in postmenopausal women. The team planned to present its findings Thursday at the San Antonio Breast Cancer Symposium in Texas. Research presented at medical meetings is not analyzed by outside experts, unlike studies that appear in peer-reviewed medical journals, and all such findings should be considered preliminary.

Launched in 1991, the WHI includes more than 161,000 U.S. women between the ages of 50 and 79. Two groups were part of the trial -- women who had had hysterectomies and took estrogen alone as hormone replacement therapy and a group that took estrogen plus progestin hormone replacement therapy.

The combination therapy trial was halted in 2002 after it became clear those women were at increased risk for heart disease and breast cancer.

In the new look at the estrogen-only group, Ragaz said, "we looked at women who did not have high-risk features." They found that women with no prior history of benign breast disease had a 43 percent reduction breast cancer risk on estrogen; women with no family history with a first-degree relative with breast cancer had a 32 percent risk reduction and women without previous hormone use had a 32 percent reduced risk.

Overall, the 10,000-plus participants had a 20 percent reduction in breast cancer risk, a reduction that approached statistical significance, Ragaz said.

After their review, Ragaz said they concluded that using estrogen alone, particularly if begun in women less than 60 who don't have a uterus, can help reduce breast cancer risk.

The new review did not receive drug company funding, Ragaz said.

"Women without a uterus should be totally safe and benefit a great deal [with estrogen-only use]," he said.

Yet, more research is needed to find the best treatment regimen, decide who are the ideal candidates and to figure out exactly why the estrogen only reduces risk in some women, he said.

The findings don't actually include anything new, said Dr. Rowan Chlebowski, a WHI investigator who is chief of medical oncology/hematology at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. The same results, he said, were published back in 2006, when the WHI investigators reported on the estrogen-only arm of the study.

"These results have been around for a long period of time," he said. But, he added that "you have to be cautious about interpreting subgroups."

To say estrogen is protective, Chlebowski said, is a little strong. The overall reduction in breast cancer risk found among the 10,000 participants -- 20 percent -- didn't reach significance from a statistical point of view, he said.

When looked at by subgroups -- those with no previous benign breast disease, those with no prior HRT use, those with no first-degree relative with breast cancer -- the reductions were significant.

"The message is pretty much unchanged by this [new review]," he said, adding "I guess it will get people to look at the data again."

More information

To learn more about HRT, visit the National Library of Medicine.

SOURCES: Joseph Ragaz, M.D., medical oncologist and clinical professor, Faculty of Medicine & School of Population & Public Health, University of British Columbia, Vancouver, Rowan Chlebowski, M.D., Ph.D., professor in residence and chief, medical oncology/hematology, Los Angeles Biomedical Research Center, Harbor-UCLA Medical Center, Los Angeles; Dec. 9, 2010, presentation, San Antonio Breast Cancer Symposium, Texas

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Pioneering Hormone Therapist to Host Free Health Seminar
2. Hormone May Prevent Aggressive Breast Cancer
3. Bonding Hormone Might Help Some With Autism
4. WHI data confirm short-term heart disease risks of combination menopausal hormone therapy
5. Early On, Hormone Therapy May Raise Womens Heart Risks
6. Testicular Cancer Survivors May Have Hormone Deficiency
7. Stress hormone, depression trigger obesity in girls
8. Buy HGH Website Educates Consumers on the Pros and Cons of Human Growth Hormone Supplements
9. Hormone thought to slow aging associated with increased risk of cancer death
10. Hormone Outperforms Insulin in Diabetic Mice
11. High Hormone Level Linked to Cancer Death in Older Men
Post Your Comments:
Related Image:
Estrogen-Only Hormone Therapy May Reduce Breast Cancer Risk for Some
(Date:12/1/2015)... ... December 01, 2015 , ... ... Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation recognizes Tympani as ... Cisco Unified Contact Center solutions targeted to the high-end enterprise contact center marketplace. ...
(Date:11/30/2015)... ... ... Trevor and Taylor Crabb have unveiled an exciting new campaign to unite ... States. This hybrid crowdfunding campaign is designed to provide the Crabb brothers’ ... offering corporate sponsors with some great marketing deliverables with the brothers for the 2016 ...
(Date:11/30/2015)... ... ... The National Association of Professional Women (NAPW) honors Dawn ... She is recognized with this prestigious distinction for leadership in estate sales and moving. ... 850,000 members and over 200 operating Local Chapters. , “I’m pleased to welcome Dawn ...
(Date:11/30/2015)... ... December 01, 2015 , ... ... to offer individual vision insurance plans on . The multi-carrier insurance ... rate and review products, allowing consumers to compare, quote and match plans to ...
(Date:11/30/2015)... ... November 30, 2015 , ... During the National ... caregivers and held two webinars on topics of ‘Medical and Palliative Care Decisions,’ ... at . , With a loved one's diagnosis of mesothelioma, the ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)...  QT Vascular Ltd., together with its subsidiaries (the ... TriReme Medical LLC and Quattro Vascular Pte. Ltd., collectively ... assembly and distribution of advanced therapeutic solutions for the ... announce that a three-judge panel of the ... Federal Circuit ("Federal Circuit") has unanimously granted the Group ...
(Date:11/30/2015)... ) has ... Market 2015-2019" report to their offering. ... of the "Orphan Drugs Market 2015-2019" ... and Markets ( ) has announced the ... report to their offering. ...
(Date:11/30/2015)... -- IBA Molecular North America, Inc. (IBAMNA), a U.S. leader ... as of January 1, 2016, it will do business ... rebrand the company reflects a refined vision for the ... relationship with Zevacor Molecular.  Both IBAMNA and Zevacor Molecular ... Peter Burke , Vice President Sales and ...
Breaking Medicine Technology: